Logo
x

Search

Subscribe Now

astraZeneca

PharmaShots Weekly Snapshots (July 29 – August 02, 2024)

PharmaShots Weekly Snapshots (July 29 – August 02, 2024)

  • August 2, 2024
AstraZeneca Provides Update on P-III (AMPLIFY) Trial of Calquence for Treating Chronic Lymphocytic Leukemia

AstraZeneca Provides Update on P-III (AMPLIFY) Trial of Calquence for Treating Chronic Lymphocytic Leukemia

  • July 29, 2024
AstraZeneca’s Tagrisso Plus Chemotherapy Receives Health Canada’s Approval to Treat Advanced Lung Cancer

AstraZeneca’s Tagrisso Plus Chemotherapy Receives Health Canada’s Approval to Treat Advanced Lung Cancer

  • July 12, 2024
AstraZeneca’s Tagrisso Plus Chemotherapy Receives the EC’s Approval to Treat EGFR-Mutated Advanced Lung Cancer

AstraZeneca’s Tagrisso Plus Chemotherapy Receives the EC’s Approval to Treat EGFR-Mutated Advanced Lung Cancer

  • July 5, 2024
AstraZeneca at ATS’24: Andrew Menzies-Gow from AstraZeneca in a Stimulating Conversation with PharmaShots

AstraZeneca at ATS’24: Andrew Menzies-Gow from AstraZeneca in a Stimulating Conversation with PharmaShots

  • July 3, 2024
AstraZeneca’s Lynparza Plus Imfinzi Receives the CHMP’s Positive Opinion for Treating Endometrial Cancer

AstraZeneca’s Lynparza Plus Imfinzi Receives the CHMP’s Positive Opinion for Treating Endometrial Cancer

  • July 2, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.